Health AI Central
Share:
Peer-Reviewed Publication
BJUI Compass2025;6(1):e456.January 1, 2025Journal Article

Focal therapy of prostate cancer: Use of artificial intelligence to define tumour volume and predict treatment outcomes.

Wayne G Brisbane1, Alan M Priester1,2, Anissa V Nguyen1, Mark Topoozian1, Sakina Mota2, Merdie K Delfin1, Samantha Gonzalez1, Kyla P Grunden1, Shannon Richardson1, Shyam Natarajan1,2, Leonard S Marks1
1Department of Urology, Institute of Urologic Oncology UCLA Los Angeles California USA.
2Avenda Health Culver City California USA.
PubMed PMC DOI PDF

Abstract

OBJECTIVES: The aim of this study is to evaluate new software (Unfold AI) in the estimation of prostate tumour volume (TV) and prediction of focal therapy outcomes. SUBJECTS/PATIENTS AND METHODS: Subjects were 204 men with prostate cancer (PCa) of grade groups 2-4 (GG ≥ 2), who were enrolled in a trial of partial gland cryoablation (PGA) at UCLA from 2017 to 2022. Magnetic resonance imaging (MRI)…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.